Quantifying the strength of ligand antagonism in TCR triggering

被引:18
作者
Van Den Berg, HA [1 ]
Burroughs, NJ [1 ]
Rand, DA [1 ]
机构
[1] Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England
基金
英国惠康基金;
关键词
D O I
10.1006/bulm.2002.0302
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Triggering of the T cell receptor (TCR) may be antagonized by ligands that are slight variants of the immunogenic peptide. This paper proposes a mathematical model to quantify the strength of the antagonistic effect. The model is based on the kinetics of association and dissociation of TCR and peptide/major histocompatibility (pMHC) molecules, and incorporates TCR triggering according to a kinetic proofreading mechanism. Model analysis indicates that while the average lifetime of the TCR/pMHC complex is the basic determinant of the contribution to TCR triggering made by the ligand, the affinity of the ligand and its MHC presentation level are also important. However, these contributions depend on the kinetic limitation regime. There is a continuum of limitation regimes, at the extremes of which are found TCR limitation and MHC limitation. Both ligand affinity and TCR and pMHC densities determine whether TCR triggering is TCR limited or MHC limited. The changing importance of affinity and antigen presentation level under various kinetic limitation regimes may explain the respective roles of antagonistic and agonistic self peptides in thymic selection. Moreover, TCR down-regulation under TCR-limited conditions may allow the T cell to differentiate between the average lifetime of the TCR/pMHC complex and the presentation level of the ligand. A method for experimental differentiation between passive and active antagonistic effects is proposed which exploits the differences between TCR and MHC limitation. (C) 2002 Society for Mathematical Biology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:781 / 808
页数:28
相关论文
共 69 条
[41]   Three-dimensional segregation of supramolecular activation clusters in T cells [J].
Monks, CRF ;
Freiberg, BA ;
Kupfer, H ;
Sciaky, N ;
Kupfer, A .
NATURE, 1998, 395 (6697) :82-86
[42]   INHIBITION OF T-CELL RECEPTOR EXPRESSION AND FUNCTION IN IMMATURE CD4+CD8+ CELLS BY CD4 [J].
NAKAYAMA, T ;
JUNE, CH ;
MUNITZ, TI ;
SHEARD, M ;
MCCARTHY, SA ;
SHARROW, SO ;
SAMELSON, LE ;
SINGER, A .
SCIENCE, 1990, 249 (4976) :1558-1561
[43]   COCLUSTERING CD45 WITH CD4 OR CD8 ALTERS THE PHOSPHORYLATION AND KINASE-ACTIVITY OF P56LCK [J].
OSTERGAARD, HL ;
TROWBRIDGE, IS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :347-350
[44]  
Penna D, 1999, J IMMUNOL, V163, P50
[45]  
Peterson DA, 1999, J IMMUNOL, V162, P3117
[46]   Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specifre receptors [J].
Preckel, T ;
Grimm, R ;
Martin, S ;
Weltzien, HU .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (10) :1803-1813
[47]   Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade [J].
Purbhoo, MA ;
Sewell, AK ;
Klenerman, P ;
Goulder, PJR ;
Hilyard, KL ;
Bell, JI ;
Jakobsen, BK ;
Phillips, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4527-4532
[48]   Altered T cell receptor ligands trigger a subset of early T cell signals [J].
Rabinowitz, JD ;
Beeson, C ;
Wulfing, C ;
Tate, K ;
Allen, PM ;
Davis, MM ;
McConnell, HM .
IMMUNITY, 1996, 5 (02) :125-135
[49]   Kinetic discrimination in T-cell activation [J].
Rabinowitz, JD ;
Beeson, C ;
Lyons, DS ;
Davis, MM ;
McConnell, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1401-1405
[50]   Ligand-specific oligomerization of T-cell receptor molecules [J].
Reich, Z ;
Boniface, JJ ;
Lyons, DS ;
Borochov, N ;
Wachtel, EJ ;
Davis, MM .
NATURE, 1997, 387 (6633) :617-620